A carregar...
Dose-dense Temozolomide: Is It Still Promising?
Glioblastoma (GBM) has proven to be incurable despite recent progress on its standard of care using temozolomide (TMZ) as the main trunk of initial therapy for newly diagnosed GBM. One of the main reasons accounting for the dismal prognosis is attributed to lack of active therapeutic regimens at rec...
Na minha lista:
| Publicado no: | Neurol Med Chir (Tokyo) |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
The Japan Neurosurgical Society
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4533399/ https://ncbi.nlm.nih.gov/pubmed/25744349 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2176/nmc.ra.2014-0277 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|